Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson
New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…






